Evidence map›Paper›PMID 41729213›Full record

ArticleDiscover oncology2026

Integrated single-cell multi-omics analysis unveils heterogeneity in the prostate cancer tumor microenvironment.

Zongwei Mei, Chen Chen, Jilong Zhou, Qing Jiang

Abstract read
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zongwei MeiDepartment of Urology, The Second Afliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
Chen ChenDepartment of Urology, The Second Afliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
Jilong ZhouDepartment of Urology, The Second Afliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
Qing JiangDepartment of Urology, The Second Afliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China. 300899@hospital.cqmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate cancer (PCa) is a heterogeneous disease characterised by a highly complex cellular ecosystem within its tumour microenvironment (TME). However, the crosstalk patterns between tumour and immune cells remain poorly understood.

methodsSingle cell RNA sequencing, spatial transcriptomics and bulk RNA-seq data were integrated to explore key Tregs cells modules and genes involved in PCa processes in the tumour microenvironment.

resultsWe found that the oxidative phosphorylation and apoptosis signaling pathways of Tregs cells in PCa patients is significantly activated. Tregs cells and Tumour cells may interact through PPIA-BSG ligand-receptor pairs to form an immunosuppressive microenvironment. Using high-dimensional weighted gene co-expression network analysis, we identified 6 key functional modules in Tregs from PCa. The spatial localization of these modules in tumor tissues was further validated using spatial transcriptomics data. Subsequent differential modules analysis revealed that the M2 module exhibited the most significant changes. A Cox proportional hazards model was then constructed based on this module, leading to the identification of 8 key prognostic genes, including ANKRD37, CHORDC1, DOK2, HSPA6, RGCC, SERPINH1, STIP1, and UBB. These genes hold promise as potential molecular markers for the diagnosis and prognostic evaluation of PCa.

conclusionThese findings reveal potential ligand-receptor interactions in the tumour microenvironment of PCa patients and key Tregs cell module genes involved in the formation of an immunosuppressive microenvironment. Targeting these cells and genes will help advance the treatment of PCa.

Indexed as

Prostate cancerSingle-cell multi omicsTregs cellsTumour immunityTumour microenvironment

Identifiers

PMID41729213
PMCPMC13035951

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.